Literature DB >> 16316423

Elevated serum levels of soluble E-cadherin in patients with primary Sjögren's syndrome.

M V Jonsson1, S Salomonsson, G Øijordsbakken, K Skarstein.   

Abstract

The aim of this study was to investigate serum levels of soluble E-cadherin (sE-cadherin) in relation to lymphocytic organization and to characterize the expression of E-cadherin and integrin alphaEbeta7/CD103 in salivary gland epithelium of patients with Sjögren's syndrome (SS). Serum levels of sE-cadherin were significantly increased in SS compared to non-SS and nonsignificantly in germinal centre (GC)+ compared to GC- patients. Membrane-bound E-cadherin was detected on the majority of acinar and ductal epithelial cells in both SS and non-SS. alphaEbeta7/CD103-positive cells were found scattered in focal infiltrates and GC, and in small clusters close to ductal and acinar epithelium at an increased level in SS compared to non-SS. Interestingly, E-cadherin-positive cells were detected randomly dispersed in focal lymphocytic infiltrates in 10/21 patients. By double-labelling, the cells with the E-cadherin-positive component were identified as CD68(+) macrophages. Elevated serum levels of sE-cadherin indicate an increased epithelial cell turnover and shedding, and sE-cadherin deserves further analysis as a potential diagnostic tool for SS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316423     DOI: 10.1111/j.1365-3083.2005.01698.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

Review 1.  Animal models of Sjögren's syndrome.

Authors:  Malin V Jonsson; Nicolas Delaleu; Roland Jonsson
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 2.  E-Cadherin Signaling in Salivary Gland Development and Autoimmunity.

Authors:  Margherita Sisto; Domenico Ribatti; Sabrina Lisi
Journal:  J Clin Med       Date:  2022-04-17       Impact factor: 4.964

3.  Focal lymphocytic sialadenitis and ectopic germinal centers in oral reactive lesions and primary Sjögren's syndrome: a comparative study.

Authors:  Evânio Vilela Silva; Luciana Yamamoto Almeida; Karen Cristine Bortoletto; Isabela Barbosa Quero; Fernanda Carolina Jacomini; Bruno Augusto Benevenuto de Andrade; Heitor Albergoni Silveira; Andressa Duarte; Flávio Calil Petean; Eduardo Melani Rocha; Alfredo Ribeiro-Silva; Román Carlos; Jorge Esquiche León
Journal:  Rheumatol Int       Date:  2021-07-20       Impact factor: 3.580

4.  Long Non-Coding RNAs Modulate Sjögren's Syndrome Associated Gene Expression and Are Involved in the Pathogenesis of the Disease.

Authors:  Marzia Dolcino; Elisa Tinazzi; Claudio Vitali; Nicoletta Del Papa; Antonio Puccetti; Claudio Lunardi
Journal:  J Clin Med       Date:  2019-09-01       Impact factor: 4.241

5.  Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma.

Authors:  Phongsaran Kimawaha; Apinya Jusakul; Prem Junsawang; Watcharin Loilome; Narong Khuntikeo; Anchalee Techasen
Journal:  J Gastrointest Oncol       Date:  2020-04

Review 6.  Epstein-Barr virus in systemic autoimmune diseases.

Authors:  Anette Holck Draborg; Karen Duus; Gunnar Houen
Journal:  Clin Dev Immunol       Date:  2013-08-24

7.  Transcriptome Analysis of CCR9+ T Helper Cells From Primary Sjögren's Syndrome Patients Identifies CCL5 as a Novel Effector Molecule.

Authors:  Anneline C Hinrichs; Sofie L M Blokland; Ana P Lopes; Catharina G K Wichers; Aike A Kruize; Aridaman Pandit; Timothy R D J Radstake; Joel A G van Roon
Journal:  Front Immunol       Date:  2021-07-27       Impact factor: 7.561

Review 8.  Cadherin Signaling in Cancer and Autoimmune Diseases.

Authors:  Margherita Sisto; Domenico Ribatti; Sabrina Lisi
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.